Ob receptor and methods for the diagnosis and treatment of body weight disorders, including obesity and cachexia
US6548269B1 · kind B1 · utility
Assignee
Inventors
Key dates
| Filing date | Apr 26, 1996 |
| Grant date | Apr 15, 2003 |
| Priority date | — |
| Expiry date | Apr 26, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the discovery, identification and characterization of nucleotides that encode Ob receptor (ObR), a receptor protein that participates in mammalian body weight regulation. The invention encompasses obR nucleotides, host cell expression systems, ObR proteins, fusion proteins, polypeptides and peptides, antibodies to the receptor, transgenic animals that express an obR transgene, or recombinant knock-out animals that do not express the ObR, antagonists and agonists of the receptor, and other compounds that modulate obR gene expression or ObR activity that can be used for diagnosis, drug screening, clinical trial monitoring, and/or the treatment of body weight disorders, including but not limited to obesity, cachexia and anorexia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.